Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-015958
Filing Date
2025-06-06
Accepted
2025-06-06 16:05:26
Documents
1
Period of Report
2025-06-04

Document Format Files

Seq Description Document Type Size
1 form4-06062025_040606.html 4  
1 form4-06062025_040606.xml 4 3998
  Complete submission text file 0001415889-25-015958.txt   5494
Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPWY, STE. 250 AUSTIN TX 78746
Business Address
Quinn Anthony G. (Reporting) CIK: 0001532219 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39319 | Film No.: 251030558

Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 857-529-5908
Generation Bio Co. (Issuer) CIK: 0001733294 (see all company filings)

EIN.: 814301281 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)